Skip to main content
Clinical Trials/NCT05935410
NCT05935410
Recruiting
Not Applicable

Combined Diabetes Education/Skills Training and Social Needs Resolution Intervention for Older African Americans With Poorly Controlled Type 2 Diabetes (DM Social Needs)

Medical College of Wisconsin1 site in 1 country100 target enrollmentAugust 1, 2023
ConditionsType 2 Diabetes

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Type 2 Diabetes
Sponsor
Medical College of Wisconsin
Enrollment
100
Locations
1
Primary Endpoint
Glycemic Control (Hemoglobin A1C [HbA1C])
Status
Recruiting
Last Updated
8 months ago

Overview

Brief Summary

This study will test the preliminary efficacy of a nurse case-manager, telephone-delivered intervention that provides diabetes self-management education and skills training and resolves the unmet social needs of older African Americans with poorly controlled type 2 diabetes by randomizing 100 African Americans aged 50 years and older with poorly controlled type 2 diabetes to the Combined Diabetes Education/Skills Training and Social Needs Resolution (DM Social Needs) Intervention (n=50) and usual care (n=50) arms.

The aims of this study are:

Aim 1: Test the preliminary efficacy of the DM Social Needs intervention on clinical outcomes in older AAs with uncontrolled type 2 diabetes.

Aim 2: Test the preliminary efficacy of the DM Social Needs intervention on patient reported outcomes in older AAs with uncontrolled type 2 diabetes.

Registry
clinicaltrials.gov
Start Date
August 1, 2023
End Date
November 1, 2025
Last Updated
8 months ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Aprill Z. Dawson, PhD, MPH

Assistant Professor

Medical College of Wisconsin

Eligibility Criteria

Inclusion Criteria

  • Age 50 and older;
  • self-identified as African American or Black;
  • self-reported diagnosis of T2DM;
  • HbA1C \>=8% at the screening visit.

Exclusion Criteria

  • self-reported participation in other diabetes clinical trials;
  • alcohol or drug abuse or dependency as assessed by the CAGE-AID;
  • Mental confusion at screening assessment suggesting significant dementia;
  • life expectancy \< 6 months at screening assessment.

Outcomes

Primary Outcomes

Glycemic Control (Hemoglobin A1C [HbA1C])

Time Frame: Change in baseline HbA1C at 6 months post intervention follow-up

About 10cc of blood will be drawn by trained phlebotomists and sent to the lab for testing.

Study Sites (1)

Loading locations...

Similar Trials